google-site-verification: googlec7193c3de77668c9.html

Biomarker-matched drug combos shrink treatment-resistant melanoma in preclinical models

[
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug combinations based on specific tumor biology to improve outcomes for treatment-resistant advanced melanoma.


Source link

Advertisements
Views: 1

See also  Benefit of thick liquids in Alzheimer disease and dysphagia unclear

Check Also

WHO declares Hantavirus outbreak linked to cruise ship is over

On Thursday, the WHO said more than 650 contacts had been identified and followed up …

COVID’s lingering shadow faded after omicron—but not for everyone

[ For some, COVID-19 did not end when the infection cleared. A long-term study found …

Low-cost treatment for multiple sclerosis shown to be as effective as standard therapy

[ A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that …

Leave a Reply

Available for Amazon Prime